Supernus Pharmaceuticals | Acreedores Comerciales



Trade Creditors Cambio Fecha
Abbott USD 11.7B 8.8B 2024-12
ANI Pharmaceuticals USD 45.66M 15.23M 2024-12
Aurora Cannabis CAD 29.52M 20.78M 2024-12
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Canopy Growth CAD 25.49M 50.74M 2024-06
Corcept Therapeutics USD 15.38M 3.21M 2024-12
Eisai JPY 64.53B 1.79B 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Indivior 50M 4M 2024-09
Novo Nordisk 24.08B 5.68B 2024-09
Pacira USD 19.13M 234K 2024-12
Perrigo USD 495.2M 36.7M 2024-12
Pfizer USD 5.63B 319M 2024-12
Supernus Pharmaceuticals USD 4.59M 1.8M 2024-12
United Therapeutics 6M 357.9M 2024-12
Xeris Pharmaceuticals USD 2.29M 5.16M 2024-12



Supernus Pharmaceuticals Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.